NeuroKappa Therapeutics

NeuroKappa Therapeutics

Pre-clinical
San Diego, United StatesFounded 2020neurokor.com

The name of “Neurokappa” came from the concept that molecules targeting to kappa opioid receptor may have huge drug development values. Some of the existing medications including naloxone, a medication used for opioid overdose rescue. Some of the compounds as kappa opioid receptor agonists have potential therapeutic values in stroke therapy, pain management, depression, and addiction therapy.

Founded
2020
Focus
Small Molecules

About

The name of “Neurokappa” came from the concept that molecules targeting to kappa opioid receptor may have huge drug development values. Some of the existing medications including naloxone, a medication used for opioid overdose rescue. Some of the compounds as kappa opioid receptor agonists have potential therapeutic values in stroke therapy, pain management, depression, and addiction therapy.

Company Info

TypePrivate
Founded2020
LocationSan Diego, United States
StagePre-clinical
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile